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Purpose
Monitoring disease activity of chronic arthritis is still a
major challenge in clinical praxis. Activated macrophages
play a crucial role during joint inflammation. Expression
of myeloid related protein 14 (MRP14) by activated mac-
rophages correlates with disease activity in different forms
of arthritis. We analyse the use of Cy5.5-labelled antibod-
ies against MRP14 for monitoring of inflammation activ-
ity in experimental model of arthritis using optical
molecular imaging.
Methods
Anti-MRP14 antibody was coupled to Cy5.5-NHS-ester.
Collagen-induced arthritis was analysed in male DBA/
1lacJ-mice. Fluorochromes (anti-MRP14-Cy5.5. or IgG-
Cy5.5 as control) were injected in amounts of 2 nm Cy5.5
per animal at day 25 and Fluorescence Reflectance Imag-
ing (FRI) was performed from day 26 to 30 and signal-to-
noise-ratios (SNR) were calculated. For correlation of
imaging findings expression of MRP14 was confirmed by
immunohistochemistry of inflamed tissue and determi-
nation of serum levels of MRP14 by ELISA. A one-way
ANOVA was performed for statistical analysis.
Results
Injection of Anti-MRP14-Cy5.5 resulted in SNR which
was more than three-fold higher compared to those after
IgG-Cy5.5-injection (6359.2 vs. 2087.5, p < 0.01), con-
firming that the measurable signal was due to probe-to-
target-binding. Fluorescence intensity correlated with
clinical disease score and MRP14 serum levels: highly
symptomatic mouse (clinical score 3/4) vs. asymptomatic
mouse (1/4): Fluorescence Intensity 10256 vs. 4459 AU;
MRP14 serum level 1450 vs. 83 ng/ml.
Conclusion
Anti-MRP14-Cy5.5 combined with FRI allows sensitive
and specific detection of inflammatory activity repre-
sented by MRP14 expression in vivo. Thus imaging dis-
ease activity of inflammatory arthritis at high resolution
in living animals is feasible using this approach.
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